Amedeo Smart

Free Medical Literature Service


 

Amedeo

Colorectal Neoplasms

  Free Subscription

13.04.2026

2 Ann Surg
2 Ann Surg Oncol
1 BMC Cancer
3 BMC Gastroenterol
1 BMJ Oncol
2 Br J Cancer
1 Cancer Lett
1 Clin Cancer Res
3 Eur J Cancer
5 Gastrointest Endosc
2 Gut
2 Int J Cancer
2 J Clin Oncol
3 J Natl Cancer Inst
1 J Surg Oncol
1 Oncol Rep
1 PLoS Genet
2 PLoS One



    Ann Surg

  1. WILD C, Freeman JQ, Jamal A, Tiro J, et al
    Residing in a Food Desert is Associated with the Development of Colon Cancer Recurrence following Surgical Resection.
    Ann Surg. 2026 Apr 7. doi: 10.1097/SLA.0000000000007061.
    >> Share

  2. NUMATA M, Yamaguchi T, Shiomi A, Inada R, et al
    Prospective Multicenter Comprehensive Survey on Male Sexual Dysfunction following Laparoscopic, Robotic, and Transanal Approaches for Rectal Cancer (the LANDMARC Study).
    Ann Surg. 2026;283:869-877.
    >> Share


    Ann Surg Oncol

  3. CHINEN Y, Hata T, Takeda M, Sekido Y, et al
    ASO Visual Abstract: Clinical Significance of Bromodomain Containing Protein 9 in Colorectal Cancer.
    Ann Surg Oncol. 2026 Apr 8. doi: 10.1245/s10434-026-19524.
    >> Share

  4. MARTINEZ AE, Webber A, Davis L, Nigam A, et al
    ASO Visual Abstract: Disparities in Surgical Care of Patients with Colorectal Cancer Liver Metastases.
    Ann Surg Oncol. 2026 Apr 5. doi: 10.1245/s10434-026-19603.
    >> Share


    BMC Cancer

  5. DU Z, Li DZ, Xu ZL, Li Q, et al
    Identification and verification of an eight-gene prognostic signature for colorectal cancer based on tumor-associated macrophages.
    BMC Cancer. 2026 Apr 6. doi: 10.1186/s12885-026-15965.
    >> Share


    BMC Gastroenterol

  6. SHINWARI H, Osama M, Nawaz AB, Khan M, et al
    Diabetes and socioeconomic status as key risk factors for colorectal cancer in the pashtun population: a case-control study.
    BMC Gastroenterol. 2026 Apr 9. doi: 10.1186/s12876-026-04759.
    >> Share

  7. CHEN Y, Deng S, Hakenberg P, Li C, et al
    DeepSeek-R1 vs. OpenAI o1 in colorectal cancer screening: a binational evaluation.
    BMC Gastroenterol. 2026;26:217.
    >> Share

  8. MASINA T, Chokotho L, Noah P, Mulwafu W, et al
    Evaluating clinicopathological pattern and management of colorectal cancer for adult patients presenting at Queen Elizabeth Central Hospital: a 10-year retrospective review.
    BMC Gastroenterol. 2026 Apr 7. doi: 10.1186/s12876-026-04800.
    >> Share


    BMJ Oncol

  9. GHOLAMI S, Saeed A, Baca Y, Hinton A, et al
    CXCR4 mRNA overexpression: an indicator of poor survival and predictor of response to immune checkpoint inhibitors in patients with metastatic colorectal cancer.
    BMJ Oncol. 2026;5:e001003.
    >> Share


    Br J Cancer

  10. RAHKOLA O, Tuomisto A, Elomaa H, Karjalainen H, et al
    Significance of tumor infiltrating granulocytes and neutrophil extracellular traps in colorectal cancer.
    Br J Cancer. 2026 Apr 7. doi: 10.1038/s41416-026-03409.
    >> Share

  11. HUISMANS MA, Gort EH, van der Heijden LT, Guven Mese SM, et al
    Safety and efficacy of lapatinib, binimetinib, and vinorelbine for RAS mutant metastatic colorectal cancer: results of the RASTRIC Phase I/II trial.
    Br J Cancer. 2026 Apr 7. doi: 10.1038/s41416-026-03398.
    >> Share


    Cancer Lett

  12. ZHENG Y, Liu H, Liu X, He W, et al
    The Therapeutic Landscape and Underlying Mechanisms of Taurine in Colorectal Cancer.
    Cancer Lett. 2026 Apr 7:218480. doi: 10.1016/j.canlet.2026.218480.
    >> Share


    Clin Cancer Res

  13. AREF AT, Pathan M, Habib R, Hains PG, et al
    Proteomics-Driven Risk Stratification in Stage III Colon Cancer: A Validated Prognostic Signature for Recurrence Prediction using three independent cohorts.
    Clin Cancer Res. 2026 Apr 9. doi: 10.1158/1078-0432.CCR-25-3200.
    >> Share


    Eur J Cancer

  14. AMBROSINI M, Gallois C, Gandini A, Lecanu A, et al
    From clusters to clinic: An 8-gene signature combined with mucinous component stratifies benefit of anti-CTLA-4 addition to anti-PD-1 in dMMR/MSI-H metastatic colorectal cancer.
    Eur J Cancer. 2026;239:116731.
    >> Share

  15. DERANGERE V, Lecuelle J, Lepage C, Salem OA, et al
    Corrigendum to "Combination of CDX2H-score quantitative analysis with CD3 AI-guided analysis identifies patients with a good prognosis only in stage III colon cancer" [In European Journal of Cancer, Volume 172, 2022, Pages 221-230, ISSN 0959-8049].
    Eur J Cancer. 2026;239:116586.
    >> Share

  16. FOURNIER E, Schaffar R, Staehelin K, Rouxel N, et al
    Rising early-onset colorectal cancer in Switzerland despite declining incidence in older adults: A nationwide population-based study, 1980-2021.
    Eur J Cancer. 2026;239:116707.
    >> Share


    Gastrointest Endosc

  17. CHANG PW, Nguyen DD, Kong N, Wang D, et al
    Impact of artificial intelligence-assisted colonoscopy on gastroenterology fellow performance: a pragmatic randomized controlled trial.
    Gastrointest Endosc. 2026;103:1043-1051.
    >> Share

  18. TAGHIAKBARI M, Calce SI, Rex DK, Oleksiw M, et al
    Required withdrawal times to meet adenoma detection targets during colonoscopy.
    Gastrointest Endosc. 2026;103:1054-1063.
    >> Share

  19. ELGENDY MS, Rifai M, Taha AM, Rajab I, et al
    Accuracy of Virtual Scale Endoscopy in colorectal polyp size measurement: a Grading of Recommendations Assessment, Development and Evaluation-assessed pairwise and network meta-analysis.
    Gastrointest Endosc. 2026;103:904-920.
    >> Share

  20. TU W, Xu L
    Refining cost-effectiveness modeling of colorectal cancer screening in average-risk Asian populations: implications of risk-based stratification and free screening policies.
    Gastrointest Endosc. 2026;103:1100.
    >> Share

  21. SONG S, Liu C, Wan X
    Beyond resection with no residual microscopic disease: the critical role of histologic risk stratification in endoscopic management of suspected deep submucosal invasive colorectal cancer.
    Gastrointest Endosc. 2026;103:1101.
    >> Share


    Gut

  22. LI X, Xie M, Kang JX, Chen Y, et al
    Bifidobacterium catenulatum boosts anti-PD-1 efficacy in microsatellite stable colorectal cancer via activating CD8(+) T cells.
    Gut. 2026 Apr 9:gutjnl-2025-336025. doi: 10.1136/gutjnl-2025-336025.
    >> Share

  23. LIU C, Gong J, Luo Z, Lai P, et al
    Gut microbe alleviates stress-related cancer metastasis by oleic acid degradation.
    Gut. 2026;75:968-983.
    >> Share


    Int J Cancer

  24. LI X, Zhao Z, Stassen L, Maya AP, et al
    Head-to-head comparison of the diagnostic value of fecal and serum carcinoembryonic antigen for colorectal cancer detection.
    Int J Cancer. 2026 Apr 9. doi: 10.1002/ijc.70435.
    >> Share

  25. SEUM T, Mandic M, Safizadeh F, Hoffmeister M, et al
    At what age should people with obesity start colorectal cancer screening?
    Int J Cancer. 2026 Apr 9. doi: 10.1002/ijc.70448.
    >> Share


    J Clin Oncol

  26. NOIRET B, Perez RO, Conroy T, Brown CJ, et al
    Disruptive Analysis of Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer: Clinical and Therapeutic Distinctions Between Low- and Mid-Rectal Cancers.
    J Clin Oncol. 2026;44:1016-1027.
    >> Share

  27. MEI WJ, Wang XZ, Zhang X, Sun YM, et al
    Neoadjuvant Chemotherapy With CAPOX Versus Chemoradiation for Locally Advanced Rectal Cancer With Uninvolved Mesorectal Fascia (CONVERT): Final Results of a Phase III Trial.
    J Clin Oncol. 2026;44:970-980.
    >> Share


    J Natl Cancer Inst

  28. CAMPOY S, Drouet Y, Rochefort P, Bonadona V, et al
    Cancer risks in Lynch syndrome carriers: a systematic review and meta-analysis.
    J Natl Cancer Inst. 2026;118:589-602.
    >> Share

  29. CHIA BJ, Allegra C, Krishnamurthi S, Lieu C, et al
    A framework to evaluate surrogate endpoints at the trial level: Analysis in colorectal cancer.
    J Natl Cancer Inst. 2026 Mar 23:djag088. doi: 10.1093.
    >> Share

  30. GAWDI R, Sjolander EN, Lee JS, Whelan RL, et al
    Evaluating the role of medicaid expansion on survival in early onset colorectal cancer.
    J Natl Cancer Inst. 2026 Apr 6:djag109. doi: 10.1093.
    >> Share


    J Surg Oncol

  31. GEFEN R, Emile SH, Garoufalia Z, Dourado J, et al
    Radical Resection Compared to Local Excision for Very Old Patients With Stage 1 Rectal Cancer: An Exact-Match Analysis of the SEER Database.
    J Surg Oncol. 2026;133:563-571.
    >> Share


    Oncol Rep

  32. NAKAJO S, Uemura M, Kusafuka H, Osaki M, et al
    Hypoxic CAF studies unveil PTHrP?vitamin D?RAS axis as pivotal in the CAF.
    Oncol Rep. 2026;55:109.
    >> Share


    PLoS Genet

  33. KAFETZOPOULOS I, Taglini F, Pasquier M, Davidson-Smith H, et al
    DNMT1 loss leads to hypermethylation of a subset of late replicating domains by DNMT3A.
    PLoS Genet. 2026;22:e1012098.
    >> Share


    PLoS One

  34. SANCHEZ MA, Mercier G, Clement MC, Ortega-Deballon P, et al
    Future impacts of colectomy healthcare pathways on quality of care in bundled payment experiments, a national retrospective cohort in France.
    PLoS One. 2026;21:e0346558.
    >> Share

  35. CAI B, Lin B, Song C, Lu Z, et al
    Is there a "weekend effect" in adenoma detection rate?A single-center retrospective study.
    PLoS One. 2026;21:e0345613.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016